pirenperone

Known as: 3-(2-(4-(4-fluorobenzoyl)piperidino)ethyl)-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one, 4H-Pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-2-methyl- 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1982-2017
05101519822017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
The mouse defense test battery (MDTB) has been designed to investigate defensive reactions in Swiss-Webster mice to situations… (More)
Is this relevant?
Highly Cited
1985
Highly Cited
1985
The distribution of serotonin-2 (5-HT2) receptors in the rat brain was studied by light microscopic quantitative autoradiography… (More)
Is this relevant?
Highly Cited
1985
Highly Cited
1985
The pharmacological characteristics of the binding of [3H]8-OH-DPAT ([3H]8-hydroxy-2(di-n-propylamino)tetralin, [125I]CYP… (More)
Is this relevant?
1985
1985
Peripheral administration of the serotonin (5-HT) antagonist pirenperone produced a dose dependent inhibition of sexual behavior… (More)
Is this relevant?
1983
1983
The effect of pirenperone, a putative 5-HT2 receptor antagonist, on various 5-HT-mediated behavioural responses has been examined… (More)
Is this relevant?
1983
1983
Pirenperone, which is chemically related to ketanserin, has been reported to be a selective serotonin2 (5-HT2) antagonist and a… (More)
Is this relevant?
1983
1983
The putative 5-hydroxytryptamine (5-HT) antagonists 2-bromo-LSD, cinanserin, cyproheptadine, pizotifen, methysergide, metitepine… (More)
Is this relevant?
1983
1983
The wet-dog shake behaviour induced by 5-hydroxytryptophan (5-HTP) was used as a model of central 5-hydroxytryptamine (5-HT… (More)
Is this relevant?
1983
1983
Pirenperone (R 47465) is the prototype of a new class of psychotropic drugs, selective serotonin 5-HT2 receptor blocking agents… (More)
Is this relevant?
1983
1983
Rats were trained to discriminate between intraperitoneal injections of 0.16 mg/kg of d-lysergic acid diethylamide (d-LSD) and… (More)
Is this relevant?